Literature DB >> 7018903

Properties of Ca2+-activated protease specific for the intermediate-sized filament protein vimentin in Ehrlich-ascites-tumour cells.

W J Nelson, P Traub.   

Abstract

A Ca2+-activated neutral protease is described which, when tested against various native proteins, appears to be specific for vimentin, the 58,000-Mr subunit protein of intermediate-sized (7--11 nm) filaments in Ehrlich-ascites-tumour cells. The protein subunits of other classes of intermediate-sized filaments have been tested; neurofilament protein and glial fibrillary acidic protein are not degraded, however skeletin, the subunit protein of intermediate-sized filaments in smooth muscle, is degraded. The protease is found associated with the detergent-resistant cytoskeleton of Ehrlich-ascites-tumour cells; proteins, other than vimentin, present in this structure are not degraded. The protease is activated by Ca2+ and Sr2+ but not by other divalent cations tested: the Ca2+ concentration required for activation is 10 microM. The pH optimum is between pH 7.5 and 8.0, and the KCl concentration required for optimal activity is 100 mM. The protease is inhibited by 1-chloro-3-tosylamido-7-amino-L-2-heptanone hydrochloride and L-1-tosylamido-2-phenylethyl chloromethyl ketone but not by soybean trypsin inhibitor; inhibition by phenylmethylsulphonyl fluoride is moderate. The high substrate specificity of the protease suggests it may play a role in vimentin intermediate-sized filament protein turnover in Ehrlich-ascites-tumour cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018903     DOI: 10.1111/j.1432-1033.1981.tb05299.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

Review 1.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

2.  Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.

Authors:  J Coburn; S T Dillon; B H Iglewski; D M Gill
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Keratinization of the outer surface of the avian scutate scale: interrelationship of alpha and beta keratin filaments in a cornifying tissue.

Authors:  R B Shames; L W Knapp; W E Carver; L D Washington; R H Sawyer
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

4.  Functional changes of intermediate filaments in fibroblastic cells revealed by a monoclonal antibody.

Authors:  R Dulbecco; R Allen; S Okada; M Bowman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

5.  Müller cells in detached human retina express glial fibrillary acidic protein and vimentin.

Authors:  M Okada; M Matsumura; N Ogino; Y Honda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

6.  Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins.

Authors:  W J Nelson; P Traub
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

7.  Primary and secondary structure of hamster vimentin predicted from the nucleotide sequence.

Authors:  Y E Quax-Jeuken; W J Quax; H Bloemendal
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Interaction of the intermediate filament protein vimentin with ribosomal subunits and ribosomal RNA in vitro.

Authors:  P Traub; W J Nelson
Journal:  Mol Biol Rep       Date:  1982-11-30       Impact factor: 2.316

9.  Antagonism of [3H]fatty acid incorporation into vimentin by sodium pyruvate: pitfalls of protein acylation.

Authors:  R J Cenedella; J Mitchell
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

10.  Expression of transfected vimentin genes in differentiating murine erythroleukemia cells reveals divergent cis-acting regulation of avian and mammalian vimentin sequences.

Authors:  J Ngai; V C Bond; B J Wold; E Lazarides
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.